Search PubMedSearch

Biomedical subjects

Yuhui Wang

Publications and source records attributed to Yuhui Wang.

2 recordsLinked to original sources

Natural variants of CsSHN1 orchestrate a temporal regulatory cascade driving fruit skin netting in cucumber.

Fruit skin netting (russeting, Rs) forms when epidermal microcracks are sealed by a suberized periderm, reducing marketability. We previously identified the Rs locus (CsSHN1), which encodes an AP2/ERF transcription factor, as a major determinant of cucumber skin netting, but how fruit growth is temporally coupled to periderm formation remains unclear. Here, we integrated population genomics, time-series multiomics, DNA affinity purification sequencing (DAP-seq), and transgenic assays to decode the CsSHN1-mediated regulatory network. Six functionally relevant CsSHN1 variants were identified across 325 cucumber accessions. Allele distribution and selective sweep analyses revealed breeding-driven selection for smooth fruit skin. Overexpression of a netted allele in a smooth background induced epidermal fissures, altered cell geometry, and increased fruit size, demonstrating a dosage-sensitive effect. Time-series transcriptomics and metabolomics of near-isogenic lines (NILs) defined 3 developmental phases of netting: early suppression of lignin and trehalose genes preceding cracks, growth-driven fissuring accompanied by cell-wall remodeling and defense activation, and maturation-stage cell-wall degradation with strong induction of ligno-suberin biosynthesis. Across the cucumber genome, DAP-seq identified approximately 8,000 in vitro CsSHN1 binding sites. These binding sites were significantly enriched for the GCC-box motif and included genes involved in cutin and suberin biosynthesis. Together, these results show that CsSHN1 orchestrates fruit skin netting through a growth-coupled temporal regulatory cascade, providing a mechanistic framework for manipulating fruit epidermal properties.

Cucumis sativus

Endobronchial Ultrasound-Guided Biopsy-Derived Lung Cancer Models: A Platform for Precision Therapy.

BACKGROUND: Endobronchial ultrasound-guided transbronchial needle aspiration is used for clinical diagnosis and staging in patients with lung cancer. Nevertheless, establishing patient-derived preclinical models using needle biopsy samples remains challenging. This study describes the establishment and utility of patient-derived organoid (PDO) from endobronchial ultrasound-guided (EBUS) specimens and EBUS patient-derived xenograft (PDX). METHODS: A total of 175 EBUS specimens were used to establish PDO and PDX. "Stable establishment" organoids with passage numbers of 10 or greater were used for genomic, transcriptome, and pathologic assessment. Drug sensitivity of EBUS organoids and PDX tumors were compared with those of the matched patient. Drug screening was performed using stably established organoid models. RESULTS: We successfully established a total of 20 EBUS organoids: six EBUS-PDOs and 14 EBUS-xenograft derived organoids. These stable cancer organoid models were validated for cancer cell enrichment and pathologic assessment. Pathologic findings, exome, and transcriptome analysis found a high correlation between EBUS organoids and parental samples. EBUS organoids and PDX indicated consistent drug response patterns with their corresponding patients. A drug screening conducted on an EBUS organoid led to the discovery of potent activity of trametinib to a rare MAP2K1 K57N mutation. CONCLUSIONS: EBUS-PDO and -xenograft‒derived organoids are good options to generate stable organoids in patients with advanced stage lung cancer. The models were consistent with the genetic and pathologic features of patient tumors, and the patient's responses to treatment, supporting their utility for novel therapeutic research.

Humans